Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

  • Post author:
  • Post category:

Translational Candidate Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. Area of Impact Non-destructive treatment option for drug-resistant focal epilepsy…

Continue ReadingDevelopment of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

  • Post author:
  • Post category:

Translational Candidate A cellular therapeutic comprised of inhibitory nerve cells produced from human stem cells Area of Impact Drug-resistant chronic temporal lobe epilepsy Mechanism of Action The product candidate is…

Continue ReadingDevelopment of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy

Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

  • Post author:
  • Post category:

Therapeutic Candidate or Device NRTX-1001 is an inhibitory neuron cell therapy derived from human embryonic stem cells. Indication Focal epilepsy; drug-resistant mesial temporal lobe epilepsy. Therapeutic Mechanism NRTX-1001 is an…

Continue ReadingPhase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy